Investing.com – Abbott Labs (NYSE:) reported second-quarter earnings per share of $1.08, $0.03 better than analyst estimates of $1.05. Revenue for the quarter came in at $10 billion versus the consensus estimate of $9.69 billion.
guidance
Abbott Labs sees EPS for fiscal year 2023 between $4.30 and $4.50 against the analyst consensus of $4.40.
Abbott Labs share price closed at $107.28. It’s down -3.92% in the last three months and it’s down -3.08% in the last 12 months.
Abbott Labs has seen 3 positive EPS reviews and 12 negative EPS reviews in the last 90 days. See previous Abbott Labs stock price reaction to earnings here.
According to InvestingPro, Abbott Labs’ financial health score is an “outstanding performance.”
Check out Abbott Labs and Abbott Labs financial statements here.
Stay on top of all upcoming earnings reports by visiting the Investing.com earnings calendar